Clinical Trials on Stage II Multiple Myeloma in Austria
Total 294 results
-
Peter MacCallum Cancer Centre, AustraliaUnknownMultiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid LeukaemiaAustralia
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
Austrian Forum Against CancerUnknownMultiple Myeloma Light Chain Induced Renal InsufficiencyAustria, Czech Republic
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Arbeitsgemeinschaft medikamentoese TumortherapieMedical University of Vienna; Sanofi; Assign Data Management and Biostatistics... and other collaboratorsRecruitingNewly Diagnosed Multiple MyelomaAustria, Greece, Serbia
-
Gilead SciencesTerminated
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
Peter MacCallum Cancer Centre, AustraliaJanssen, LPRecruiting
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Austrian Breast & Colorectal Cancer Study GroupCompleted
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Austrian Forum Against CancerCompleted
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Genentech, Inc.RecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Australia, Israel
-
Austrian Forum Against CancerCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Medical University InnsbruckCompleted
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Hoffmann-La RocheTerminated
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgen; Assign Data Management and Biostatistics GmbHActive, not recruitingMultiple MyelomaAustria, Germany, Israel
-
Melbourne HealthRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Plasma Cell Myeloma | Non-hodgkin Lymphoma | Leukemia, Lymphoblastic, Acute, L1 | Leukemia, Lymphoblastic, Acute, L2Australia
-
Medical University of ViennaSuspendedMultiple MyelomaAustria
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
Stichting European Myeloma NetworkJanssen, LPRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | Plasma Cell Leukemia | MGUS | Extramedullary MyelomaItaly, Austria, Czechia, Greece, Serbia
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine